批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2018/06/15 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2022/11/16 |
SUPPL-5(补充) |
Approval |
Labeling-Container/Carton Labels,Labeling-Package Insert |
STANDARD
|
|
|
| 2022/05/05 |
SUPPL-4(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:NEOSTIGMINE METHYLSULFATE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:5MG/10ML (0.5MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 204078 |
001 |
NDA |
BLOXIVERZ |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
Yes |
Yes |
AP |
2013/05/31
|
EXELA PHARMA |
| 207042 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2015/12/28
|
HIKMA |
| 208405 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2017/04/26
|
PH HEALTH |
| 209933 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2017/09/25
|
AMPHASTAR PHARMS INC |
| 210051 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2018/06/15
|
AMNEAL |
| 209135 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2018/07/10
|
DR REDDYS |
| 210989 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2018/08/22
|
AMRING PHARMS |
| 212512 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2019/05/13
|
BE PHARMS |
| 212968 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2019/10/16
|
GLAND |
| 212804 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2021/04/05
|
MEITHEAL |
| 213074 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2021/04/20
|
CAPLIN |
| 210652 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2021/10/01
|
REGCON HOLDINGS |
| 212627 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2022/11/03
|
UMEDICA |
| 208230 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2022/11/25
|
AVET LIFESCIENCES |
| 216542 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Prescription |
No |
No |
AP |
2023/02/17
|
SAGENT PHARMS INC |
| 213244 |
001 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
5MG/10ML (0.5MG/ML) |
Discontinued |
No |
No |
AP |
2023/11/02
|
EUGIA PHARMA |
>>>活性成分:NEOSTIGMINE METHYLSULFATE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:10MG/10ML (1MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 204078 |
002 |
NDA |
BLOXIVERZ |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
Yes |
Yes |
AP |
2013/05/31
|
EXELA PHARMA |
| 207042 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2015/12/28
|
HIKMA |
| 208405 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2017/04/26
|
PH HEALTH |
| 209933 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2017/09/25
|
AMPHASTAR PHARMS INC |
| 210051 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2018/06/15
|
AMNEAL |
| 209135 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2018/07/10
|
DR REDDYS |
| 210989 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2018/08/22
|
AMRING PHARMS |
| 212512 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2019/05/13
|
BE PHARMS |
| 212968 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2019/10/16
|
GLAND |
| 212804 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2021/04/05
|
MEITHEAL |
| 213074 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2021/04/20
|
CAPLIN |
| 210652 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2021/10/01
|
REGCON HOLDINGS |
| 212627 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2022/11/03
|
UMEDICA |
| 208230 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2022/11/25
|
AVET LIFESCIENCES |
| 216542 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Prescription |
No |
No |
AP |
2023/02/17
|
SAGENT PHARMS INC |
| 213244 |
002 |
ANDA |
NEOSTIGMINE METHYLSULFATE |
NEOSTIGMINE METHYLSULFATE |
SOLUTION;INTRAVENOUS |
10MG/10ML (1MG/ML) |
Discontinued |
No |
No |
AP |
2023/11/02
|
EUGIA PHARMA |